IP Library Granted Patent US 9,169,301
Granted Patent B2
US 9,169,301 · App. 12/589,218 · Granted Oct 27, 2015

Conserved Neisserial antigens

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,169,301
App. No.
12/589,218
Granted
Oct 27, 2015
Kind
B2
Abstract

To ensure maximum cross-strain recognition and reactivity, regions of proteins that are conserved between different Neisserial species, serogroups and strains can be used. The invention provides proteins which comprise stretches of amino acid sequence that are shared across the majority of Neisseria , particularly N. meningitidis and N. gonorrhoeae.

Claims (5)

1. An immunogenic composition comprising a pharmaceutically acceptable excipient, an adjuvant, and an isolated polypeptide comprising a fragment conserved in SEQ ID NOs: 119-124, wherein the fragment conserved in SEQ ID NOs: 119-124 includes at least 10 or more contiguous amino acids in any of SEQ ID NOs: 222, 223, 226, 227, 228, 229, 230, and 231, provided that said polypeptide does not comprise a full-length Neisserial protein selected from SEQ ID NOs: 119-124.

2. The immunogenic composition of claim 1 , wherein said fragment consists of 20 or more consecutive conserved amino acids.

3. The immunogenic composition of claim 1 , where in the adjuvant comprises an aluminum salt.

4. A method of inducing an immune response against a Neisserial bacteria in a subject comprising administering the immunogenic composition of claim 1 to the subject.

5. A method of inducing an immune response against a Neisserial bacteria in a subject comprising administering the immunogenic composition of claim 3 to the subject.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 2016
From: NOVARTIS VACCINES AND DIAGNOSTICS SRL
To: GLAXOSMITHKLINE BIOLOGICALS SA
Reel/Frame 040077/0493 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2015
From: NOVARTIS AG
To: GLAXOSMITHKLINE BIOLOGICALS SA
Reel/Frame 035231/0253 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 20, 2015
From: NOVARTIS AG
To: GLAXOSMITHKLINE BIOLOGICALS SA
Reel/Frame 035219/0598 →